TXMD vs VTR · rev $1.8M vs P/E 149, rev $4.92B
TherapeuticsMD Inc (TXMD) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
TXMD currently screens at market cap $13.7M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the TXMD and VTR stock pages for the full models.
Not investment advice.